retatrutide peptide pros and cons UK 2026: Phase 3 Results There's so much talk about

Zhang A, Jia Z, Wang N, Tidwell TJ, Yang T

doi: 10.1016/0022-3999(94)90068-X 29 BowenDJGrunbergNE

11 A separate and highly replicated finding is that GLP-1 RAs directly target molecular systems implicated in neurogenesis, neurodifferentiation, neuroplasticity (Neuro-GDP), neuroprotection, and apoptosis ( 12 For example, GLP-1 RAs increase synthesis of cAMP response element-binding protein (CREB), brain-derived neurotrophic factor (BDNF), and glial-derived neurotrophic factor (GDNF), proteins integral to neurotrophic processes

However, COC use is also associated with impaired fasting glucose, insulin resistance, and an elevated risk of thromboembolic events (85)